So, Repotrectinib is this medicine that’s supposed to stop TRK, ROS1, and ALK kinases from doing their thing. It’s mostly used for treating a kind of lung cancer called ROS1-positive NSCLC and some NTRK-fusion cancers.
You can get it in these 40 mg capsules, usually in a pack of 60. The dosage regimen includes an initial intake of 160 mg once daily for the first 14 days, followed by a maintenance dose of 160 mg administered twice daily.
Reviews
There are no reviews yet.